12:00 AM
 | 
Dec 05, 2011
 |  BC Week In Review  |  Company News  |  Other News

Teva, Impax neurology news

Teva's Cephalon Inc. subsidiary filed suit against Impax in the U.S. District Court for the District of Delaware alleging an ANDA from Impax for a generic version of pain drug Fentora fentanyl infringes U.S. Patent Nos. 6,200,604 B1, 6,974,590 B2, 7,862,832 B2 and 7,862,833 B2. The '604 and '590...

Read the full 242 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >